Chen joins neurosurgery research faculty

The Department of Neurosurgery is excited to announce the joint faculty appointment of Hong Chen, PhD, as associate professor of biomedical engineering at the McKelvey School of Engineering and associate professor in the Department of Neurosurgery’s Division of Neurotechnology at the School of Medicine. 

Chen’s research focuses on new ways to utilize medical ultrasound. Her lab combines engineering, biology, and medicine to develop innovative focused ultrasound techniques to improve the lives of patients with brain diseases.

“As a biomedical engineer, Dr. Chen has worked tirelessly to develop noninvasive methods to diagnose and monitor brain tumors such as glioblastoma,” said Gregory J. Zipfel, MD, chair of the Department of Neurosurgery and the Ralph G. Dacey Distinguished Professor of Neurosurgery at the School of Medicine. “Dr. Chen has collaborated extensively with Eric Leuthardt, MD, neurosurgeon and chief of the Division of Neurotechnology, to advance personalized care for patients with malignant brain tumors. The addition of Dr. Chen to our research faculty is a great step forward for our department, the Division of Neurotechnology, and the Brain Tumor Center.”

“With her deep collaborations and connections already with several neurosurgery faculty, it makes a lot of sense for Dr. Chen to be an integral member of the neurosurgery department,” said Albert H. Kim, MD, PhD, director of the Brain Tumor Center and August A. Busch Jr. Professor of Neurosurgery. “I am excited about the scientific synergies that will emerge from having her join Dr. Alex Stegh, myself, and other Brain Tumor Center investigators in the new Neuroscience Research Building.”

“I am very excited to work even more closely with my talented neurosurgery colleagues,” said Chen. “We have made so much progress together over the past several years discovering ways to use ultrasound to collect biomarkers to better diagnose neurological diseases, as well as to deliver treatments to the brain. I am looking forward to continued collaborations that will allow us to bring our technology to patients in the coming years.”